Moderna's Phase 3 COVID-19 Vaccine Shows 95% Efficacy
November 16, 2020 at 08:33 AM EST
Moderna announced on Monday the results from phase 3 trials for the COVID-19 vaccine show the vaccine is 94.5% effective.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|